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Abstract
Because DNA damage-inducible cell cycle checkpoints
are thought to protect cells from the lethal effects of
ionizing radiation, a better understanding of the mech-
anistic functions of cell cycle regulatory proteins may
reveal new molecular targets for cancer therapy. The
two major regulatory proteins of G2 arrest are Chk1 and
p53. Yet, it is unclear how these two proteins interact
and coordinate their functional roles during radiation-
induced G2 arrest. To determine Chk1’s role in p53-
dependent G2 arrest, we used p53 proficient cells and
examined expression of G2 arrest proteins under
conditions in which G2 arrest was inhibited by the
staurosporine analog, UCN-01. We found that UCN-01
inhibited both G1 and G2 arrest in irradiated p53
proficient cells. The arrest inhibition was associated
with suppression of radiation- induced expression of
both p21 and 14-3-3 — two known p53-dependent G2
arrest proteins. The suppression occurred despite
normal induction of p53 and normal phosphorylation
of p53 at S20 and Cdc25C at S216 — the two known
substrates of Chk1 kinase activity. In contrast, we
showed that radiation- induced phosphorylation of
Chk1 at S345 was associated with binding of Chk1 to
p53, p21, and 14-3-3, and that UCN-01 inhibited S345
phosphorylation. We suggest that DNA damage–in-
duced phosphorylation of Chk1 at S345, and subse-
quent p53 binding, links Chk1 with p53 downstream
responses and may provide a coordinated interaction
between DNA damage responses and cell cycle arrest
functions.
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Introduction
DNA damage–inducible cell cycle checkpoints are thought
to play an important role in protecting cells from the lethal
effects of ionizing radiation. This suggests that cell cycle
regulatory proteins may be important therapeutic targets
for sensitizing tumors to radiotherapy. The G1 checkpoint
is the best -characterized checkpoint, but the G2 check-
point is probably more important to cellular radiore-
sistance. This is probably because premature entry into
mitosis, without allowing time for repair of DNA damage,
results in chromosome abnormalities that are lethal
to cells [1]. A better understanding of the regulatory
mechanisms of radiation-induced G2 arrest is needed to
explore the full potential of targeting G2 arrest to enhance
radiotherapy.
The human protein kinase, Chk1, is thought to play a
central role in G2 arrest [2-6]. It has been proposed that its
major mechanism is through phosphorylation of Cdc25C on
S216; thereby marking Cdc25C for nuclear export and
binding to 14-3-3 proteins. Sequestered outside the nucleus,
Cdc25C cannot dephosphorylate and activate intranuclear
Cdc2, the major initiation protein of mitosis [2,7-12]. Thus,
Chk1’s phosphorylation of Cdc25C promotes cell cycle arrest
in G2 phase. Radiation- induced DNA damage usually
initiates a strong cell cycle arrest in G2; however, it has been
difficult to show that Chk1 kinase activity is increased by
radiation [13,14].
Another protein thought to play a major role in cell cycle
arrest is the transcriptional activator, p53. Unlike Chk1,
however, p53 is well known to be activated by DNA damage.
DNA damage increases the half - life of p53, and increases
the expression of its downstream effector proteins, including
p21 and 14-3-3. p21 is a well -characterized inhibitor of
cyclin-dependent kinases and it is not only a potent inhibitor
of G1 arrest, but also plays an important role in G2 arrest
[15,16]. 14-3-3 is the  isoform of the 14-3-3 protein
family — a family of binding proteins that has been
implicated in a variety of intracellular regulatory functions,
including cell cycle arrest [17]. p53’s function in G2 arrest
appears to be mediated primarily through the cooperative
effects of p21 and 14-3-3. Cells deficient in expression of
both p21 and 14-3-3, although proficient in p53, have
defective G2 arrest and are highly sensitive to DNA-
damaging agents [16].
Neoplasia . Vol. 4, No. 2, 2002, pp. 171 –180
www.nature.com/neo
171
Address all correspondence to: Timothy J. Jorgensen, PhD, Associate Professor,
Department of Radiation Medicine, Georgetown University Medical Center, Lombardi
Cancer Center / TRB Room E212A, 3970 Reservoir Road, N.W., Washington, DC 20007 -
2197, USA. E -mail: tjorge01@georgetown.edu
1This work was supported by grant P01 -CA74175 from the National Cancer Institute of the
National Institutes of Health, U.S. Department of Health and Human Services. Flow
cytometry work was supported by the Flow Cytometry / Cell Sorting Shared Resource of the
Lombardi Cancer Center, U.S. Public Health Service grant 2P30 -CA51008.
Received 28 June 2001; Accepted 27 August 2001.
Copyright# 2002 Nature Publishing Group All rights reserved 1522-8002/02/$25.00
RESEARCH ARTICLE
An unanswered question is whether the Chk1 and p53
G2 arrest pathways work independently or communicate
with each other in some way. Direct interaction with p53 is a
possible means by which Chk1 might communicate with
DNA damage response pathways and, thus, link Chk1’s cell
cycle effects to DNA damage–induced signal transduction.
In fact, S20 of p53 is known to be one of the substrates for
Chk1 kinase activity; however, it is not clear whether Chk1
regulates p53-dependent checkpoints through phosphory-
lating p53 at S20 in vivo. Furthermore, Chk1 has been
shown to be phosphorylated in vivo in response to ionizing
radiation; however, it is unclear what the functional
consequences of Chk1 phosphorylation might be. One
possibility is that phosphorylation alters Chk1’s association
with other proteins, similar to how Cdc25C’s phosphoryla-
tion causes it to bind to 14-3-3 proteins. Therefore, we
speculated that Chk1 phosphorylation, rather than just its
kinase activity, might play an important role in communicat-
ing DNA damage response to downstream checkpoint
proteins, particularly those in the p53 radiation response
pathway.
To determine Chk1’s role in p53-dependent cell cycle
arrest, we used p53 proficient HCT116 human colon cancer
cell lines, because they had previously been characterized
for their normal G1 and G2 arrest phenotypes [18,19]. We
examined expression of cell cycle checkpoint proteins in
these cells under conditions in which radiation- induced cell
cycle arrest was inhibited by the staurosporine analog, UCN-
01. We found that UCN-01 inhibited both G1 and G2 arrest
in irradiated cells. The arrest inhibition was associated with
suppression of radiation- induced expression of both p21
and 14-3-3. The suppression occurred despite normal
induction of p53, and normal phosphorylation of p53 at S20
and Cdc25C at S216. In contrast, we showed that radiation-
induced phosphorylation of Chk1 at S345 promoted binding
of Chk1 to p53, p21, and 14-3-3, and that UCN-01
inhibited S345 phosphorylation. We suggest that DNA
damage–induced phosphorylation of Chk1 at S345, and
subsequent p53 binding, links Chk1 with p53 downstream
responses and may provide a coordinated interaction
between DNA damage responses and cell cycle arrest
functions.
Materials and Methods
Cell Lines and Cell Culture
Wild- type HCT116 human colon carcinoma cells
(HCT116/p53+ / + ), which express normal p53, p21, and
14-3-3 [19,20] and two derivatives, in which either p53
[15] or 14-3-3 [19] genes had been deleted at both of
their alleles through homologous recombination, were kindly
provided by Dr. Bert Vogelstein (Howard Hughes Medical
Institute, Johns Hopkins Oncology Center, Baltimore, MD).
The cell lines were maintained in monolayer culture in
McCoy’s 5A modified medium supplemented with 10% fetal
bovine serum, penicillin (100 U/ml) and streptomycin
(100 g/ml).
Chemicals and Irradiation
UCN-01 (7-hydroxystaurosporine) was kindly provided
by Dr. Robert J. Schultz of the Drug Synthesis and Chemistry
Branch, National Cancer Institute, and was dissolved in
dimethyl sulfoxide (DMSO) and stored at 208C. All cell
irradiation were performed using a J. L. Shepherd Mark I
137Cs irradiator (San Fernando, CA) at 1.5 to 3.0 Gy/min.
Cell Cycle Analysis
Cell cycle analysis, at 24 hours postirradiation, was
performed as described previously [21,22]. Briefly, cells
were treated with or without 100 nM of UCN-01 for 24 hours
and irradiated at 10 Gy. Cells were then harvested 24 hours
postirradiation and suspended as single cells in citrate /
DMSO buffer [250 nM sucrose, 40 mM trisodium citrite, 5%
DMSO (pH 7.6) ]. Cells were stained with propidium iodide
and analyzed by flow cytometry using FACSort (Becton
Dickinson, Franklin Lakes, NJ). The cell cycle profiles were
analyzed by Modfit software (Verity Software House).
Cell cycle analysis, at 6 hours postirradiation, was
performed with a mitosis-specific flow cytometry assay,
previously described by Juan and coworkers [23], which
uses phosphorylation-specific antibody against H3 histones
that are phosphorylated only during mitosis. Briefly, the cells
were washed with phosphate-buffered saline (PBS) and
fixed in suspension at a concentration of (4 to 6)106 cells /
ml in 2.0 ml of 1% formaldehyde in PBS for 15 minutes. The
cells were then washed with PBS and resuspended in ice-
cold 80% ethanol for up to 24 hours. After fixation, the cells
were washed twice with PBS and then suspended in 1 ml of
0.25% Triton X-100 in PBS on ice for 5 minutes. After
centrifugation, the cell pellet was suspended in 100 l PBS
containing 0.5 g of anti–H3-p polyclonal antibody (Upstate
Biotechnology, Lake Placid, NY) and 1% bovine serum
albumin (BSA) and incubated for 2 hours at room temper-
ature. The cells were rinsed with PBS containing 1% BSA,
then incubated with FITC-conjugated anti–rabbit antibody
for 30 minutes in the dark. The cells were washed again and
then resuspended in 5 g/ml of propidium iodide (PI;
Molecular Probes, Eugene, OR) and 0.1% RNase A (Sigma,
St. Louis, MO) in PBS, and incubated at room temperature
for 20 minutes before measurement.
Western Blot, Antibodies, Immunoprecipitation and
Phosphorylation Assay
Cells were washed twice with ice-cold PBS and lysed
with a Dounce homogenizer in lysis /wash buffer [50 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P40, 0.5%
sodium dexycholate, 1.0 tablet /25 ml of Complete1 pro-
tease inhibitor cocktail (Boehringer Mannheim, Indianapolis,
IN) ]. Homogenized suspensions were centrifuged at
12,000g for 10 minutes to remove debris. The amounts of
cell extracts used were adjusted for protein level by Western
blot analysis as described previously [22], using the
following antibodies: anti–p53 monoclonal antibody DO1
(Santa Cruz Biotechnology, Santa Cruz, CA), anti–p21
monoclonal antibody (WAF1) (Oncogene Research Prod-
ucts, Boston, MA), anti–14-3-3 goat polyclonal antibody
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(N-14) (Santa Cruz Biotechnology), anti–Ku70 monoclonal
antibody (N3H10) (NeoMarkers, Fremont, CA), anti–
GAPDH polyclonal antibody (Trevigen, Gaithersburg, MD),
anti–p53 monoclonal antibody DO7 (Oncogene Research
Products), anti–Cdc25C monoclonal antibody TC113
(Oncogene Research Products), anti–Chk1 monoclonal
antibody G4 (Santa Cruz Biotechnology). For immunopre-
cipitation, freshly prepared cell lysates were incubated for
2 hours at 48C on a rotator with antibodies coupled to protein
A Sepharose beads (20 l ) (Sigma). The beads were then
washed three times with the lysis /wash buffer, and applied to
SDS-PAGE.
Phosphorylation of p53 at S20 was assayed by immuno-
precipitation as described previously [24,25], with S20p-
p53, a polyclonal antibody (clone 430) obtained from New
England Biolabs (Beverly, MA), which recognizes p53
phosphorylated on S20, followed by immunoblotting with
DO7, which recognizes p53 irrespective of its phosphoryla-
tion state. Phosphorylation of p53 on S15 was assayed by
immunoprecipitation with S15p-p53 antibody (Oncogene
Research Products), a polyclonal antibody that recognizes
p53 phosphorylated on S15, followed by immunoblotting with
DO1. Immunoprecipitation of p53 was also performed using
FL-393 polyclonal antibody (Santa Cruz Biotechnology),
followed by detection with DO-1.
Phosphorylation of Cdc25C on S216 was assayed by
immunoprecipitation with S216p-Cdc25C antibody (New
England Biolabs), a polyclonal antibody that recognizes
Cdc25C phosphorylated on S216, followed by immunoblot-
ting with TC113 (Oncogene Research Products).
Phosphorylation of Chk1 on S345 was assayed by
immunoprecipitation as described previously [5 ], with
S345p-Chk1, a polyclonal antibody that recognizes Chk1
phosphorylated on S345, followed by immunoblotting with
G4, a monoclonal antibody raised against full length of the
Chk1 protein (Santa Cruz Biotechnology). Phosphorylation
of Chk2 was assayed by measuring electrophoretic gel band
shifts as described previously [26]. S345p-Chk1 and Chk2
antibodies were generously provided by Dr. Stephen J.
Elledge (Howard Hughes Medical Institute, Baylor College of
Medicine, Houston, TX).
Clonogenic Survival Assay
Cells were plated in T75 flasks and incubated appro-
ximately 16 hours. Cells were then treated with complete
medium with or without UCN-01 at 100 nM for 24 hours.
Cells were then irradiated with varying doses of gamma
rays. After additional 24 hours incubation, cells were
washed with PBS and collected following incubation with
trypsin /EDTA. Various concentrations of cells were replated
in drug- free medium in T-25 flasks, and then incubated for
12 days. Colonies were stained with crystal violet and
counted. Colonies produced from the clones of surviving
cells were counted. The fraction of surviving clonogenic
cells was calculated by dividing the number of colonies by
the number of cells seeded, and then normalizing the
surviving fraction from irradiated cultures to the zero-dose
surviving.
Results
Both G1 and G2 Checkpoints Were Abrogated in p53
Proficient Cells by UCN-01
The staurosporine analog, UCN-01, has been reported to
be a potent inhibitor of the Chk1 pathway of G2 arrest [27–
29]. We were interested in determining the effect of UCN-01
on p53-dependent cell cycle arrest functions. The HCT116
human colon cancer cell line was chosen for this study
because wild- type cells have intact p53, p21, and 14-3-3
genes and apparently normal p53-dependent checkpoint
responses [18,19], whereas its p53-deficient isogenetic
counterpart has been shown to fail to sustain both G1 and G2
arrest [15,30]. Hence, we used the wild- type HCT116 cells
as a model to evaluate the effect of UCN-01 on radiation-
induced p53-dependent cell cycle arrest.
We used two different flow cytometry methods to measure
cell cycle arrest. To simultaneously assess G1 and G2 arrest
we used a standard method of quantitating DNA histograms
of asynchronous cell populations at 24 hours postirradiation,
and measured changes in cell cycle distribution between G1,
S, and G2/M [21]. In this assay, postirradiation S phase
depletion provided a reliable index of G1 arrest, but the
combined G2 and M phases obscured accurate measure-
ment of G2 arrest. Therefore, we also used a highly sensitive
M-phase–specific three-dimensional assay, which allowed
us to measure G2 arrest as early as 6 hours postirradiation.
This technique, originally described by Juan and coworkers
[23], also uses cell number and DNA content as the first two
dimensions; however, a third dimension uses antibody
against histones phosphorylated during mitosis to distinguish
M from G2 cells. We look for a drop in the number of cells in
mitosis, caused by an arrest at the G2/M border, as an
indication of G2 arrest. By 6 hours postirradiation, wild- type
cells that were in mitosis at the time of irradiation have
already transited into G1, and M phase has not yet been
repopulated due to an arrest in G2. Thus, G2 arrest can be
detected as a depletion of M phase cells at 6 hours. When G2
arrest is inhibited, cells continue to cycle throughmitosis, and
M phase is not depleted.
When wild- type HCT116 cells were irradiated with 10 Gy
in the absence of UCN-01, it resulted in the expected G1
arrest at 24 hours, as shown by a depletion of S phase cells
(S phase from 42.0% to 12.8%) (Figure 1 ). Additionally, a
substantial G2 arrest was suggested, as shown by accumu-
lation of cells in G2/M (G2/M phase from 20.6% to 62.5%).
Treatment of the cells with UCN-01, however, inhibited both
G1 arrest and G2 arrest, and the cell cycle distributions of the
radiation/UCN-01–treated cells appeared very similar to
untreated controls, indicating that UCN-01 inhibits both G1
and G2 arrest in p53 proficient cells.
The inhibition of G2 arrest by UCN-01 was confirmed
with mitosis-specific flow cytometry (Figure 1 ). At 6 hours
postirradiation without UCN-01 there was a complete loss
of M phase cells due to G2 arrest. In the presence of
UCN-01, however, mitotic cells were still apparent in
irradiated cultures, indicating an inhibition of G2 arrest by
the drug.
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Downregulation of Radiation- Induced Increases in p21 and
14-3-3 by UCN-01 is Dependent on p53 Status
Because p21 and 14-3-3 proteins are known to
participate in G2 arrest [19,20,31], we next looked at the
effect of UCN-01 on expression of those proteins. We found
that UCN-01 significantly downregulated DNA damage–
mediated p21 and 14-3-3 induction in cells with wild- type
p53 (Figure 2 ). The finding that UCN-01 inhibits p21
induction is consistent with its ability to inhibit G1 as well
as G2 arrest. p21 is a strong inhibitor of cdk2, a major initiator
Figure 1. UCN-01 abrogates both G1 and G2 arrest in p53 proficient cells. Flow cytometric analysis of human HCT116 cells in the absence or presence of 100 nM of
UCN-01 and in the absence or presence of 10 Gy, at 6 and 24 hours. G2 arrest at 6 hours was measured as a depletion in M phase cells by a three - dimensional flow
cytometry technique, which distinguishes M phase cells based on both DNA content and staining with antibody to mitosis - specific phosphorylated histone H3 (see
Materials and Methods section ). G2 arrest at 24 hours was measured as an accumulation of cells in G2 /M phase through conventional DNA histogram flow
cytometry. Cell cycle distributions, shown in upper right of panel, were calculated from the histograms for each irradiation / drug condition.
Figure 2. UCN-01 downregulation of p21 and 14 -3 - 3. UCN-01 downregulates radiation -mediated p21 and 14 -3 - 3 induction only in p53 proficient cells without
affecting p53 protein levels, as shown by Western blot. Radiation induction of p21 and 14 -3 - 3 in the absence or presence of varying concentration of UCN-01 is
indicated. Cells were treated with UCN-01 for 24 hours and then irradiated. Cells were then harvested 24 hours postirradiation. GAPDH was used as a control of
loading.
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of progression fromG1 into S. Failure to induce p21 would be
expected to abrogate G1 arrest, and our flow cytometry data
supports this.
The reduction in p21 and 14-3-3 levels could not,
however, be attributed to a mere reduction in p53 expres-
sion, because p53 remained significantly elevated in
irradiated cells, even at UCN-01 concentrations that strongly
inhibit p21 and 14-3-3 (Figure 2 ). p53 induction was
confirmed byWestern blotting of whole-cell extracts with two
different p53 antibodies (DO7 and DO1) (Figure 3;A
and B ), and by p53 immunoprecipitation (DO1) followed
by p53 immunoblotting (FL-393) (data not shown). In
contrast, when p53 /  cells were irradiated, induction of
p21 and 14-3-3 was largely absent, yet UCN-01 did not
diminish their baseline levels (Figure 2 ), consistent with the
idea that p21 and 14-3-3 induction are p53 dependent, and
that inhibition of their expression by UCN-01 is also
dependent on p53 status. However, unlike for p21 that has
a baseline similar to p53+ / + cells, 14-3-3 baseline levels
were much higher relative to that in p53+ / + cells (Figure 2 ).
This overexpression of 14-3-3 was itself not able to induce
arrest, as these cells continued to cycle at rates similar to
p53+ / + cells, consistent with the notion that 14-3-3 helps
sustain, rather than initiate, arrest [19].
Phosphorylations of p53 on S20 and S15 are not Inhibited
by UCN-01
The above results suggest that UCN-01 suppressed
p53-dependent transactivation of p21 and 14-3-3 by a
mechanism that did not alter the intracellular levels of p53.
Because Chk1 has been shown to phosphorylate p53 at S20
in vitro, and because UCN-01 has also been shown to inhibit
Chk1 kinase activity on a synthetic substrate in vitro [28,29],
inhibition of Chk1 phosphorylation of S20 was considered a
possible in vivo mechanism by which UCN-01 might reduce
the transactivation of p21 and 14-3-3.
In vivo phosphorylation of p53 on S20 was assayed by
immunoprecipitation with an S20-p53 phosphorylation-
specific antibody followed by immunoblotting with DO7, a
monoclonal p53 antibody, as described previously [24,25].
In response to DNA damage, p53 was phosphorylated on
S20, consistent with previous reports [24,25]. Phosphoryla-
tion of p53 on S20, however, was not inhibited in the
presence of UCN-01 (Figure 3A ). Actually, when adjusted
for p53 protein level, an increase in phosphorylation was
seen in the presence of high concentrations of UCN-01. At
these concentrations, the checkpoints were completely
abrogated, suggesting that phosphorylation of p53 on S20
was insufficient to induce G2 arrest.
ATM directly phosphorylates p53 on S15 in response to
DNA damage [32,33]. Ataxia–telangiectasia cells, which are
mutated in ATM, show defective G1 and G2 arrest
accompanied by an attenuated p53 and p21 response
[34,35], similar to the effects of UCN-01 on cell cycle arrest,
leaving the possibility that ATM kinase activity was inhibited
by UCN-01. Despite the previous report that UCN-01 does
not inhibit ATM’s PI-3 kinase activity on a peptide substrate
in vitro [36], we investigated the possibility that UCN-01–
mediated checkpoint abrogation and downregulation of p21
and 14-3-3 in vivo might result from inhibiting phosphor-
ylation of p53 on S15.
In response to DNA damage, p53 was phosphorylated
on S15, consistent with previous reports [32,33]. However,
as for S20, phosphorylation of p53 on S15 was not inhibited
in the presence of UCN-01 (Figure 3B ). In fact, a slight
increase of phosphorylation was seen (Figure 3B ). These
results suggest that DNA damage-mediated phosphoryla-
tion of p53 at both S15 and S20 are normal in the presence
of UCN-01, and that the pronounced reduction of p21 and
14-3-3, as well as the inhibition of cell cycle arrest could
not be attributed to hypophosphorylation at either of these
two sites.
Phosphorylation of Cdc25c on S216 is not Changed in
Response to Either Radiation or UCN-01
Besides S20 on p53, the other known substrate for Chk1
is S216 on Cdc25C [2,8–10]. This pathway is the best-
characterized cell cycle checkpoint mechanism governing
G2 arrest and has been the pathway most strongly
Figure 3. Phosphorylation of p53 on S20 and S15 and phosphorylation of
Cdc25C on S216 in HCT116 /p53 + / + cells. After treatment with varying
concentration of UCN-01 for 24 hours, cells were irradiated at 10 Gy and
harvested 24 hours post - 10 Gy for the whole - cell extract (WCE). (A )
Phosphorylation of p53 on S20 in response to DNA damage and UCN -01 was
performed by immunoprecipitation ( IP ) with antibody against S20p -p53
followed by an immunoblotting ( IB ) with p53 antibody, DO7. p53 protein levels
were monitored by direct IB with DO7 without IP. (B ) Phosphorylation of p53
on S15 in response to DNA damage and UCN-01 was performed by IP with
antibody against S15p -p53 followed by an IB with p53 antibody, DO1. p53
protein levels were monitored by direct IB with DO1 without IP. (C )
Phosphorylation of Cdc25C on S216 in response to DNA damage and
UCN-01 was performed by IP with antibody against S216p -Cdc25C followed
by an IB with Cdc25C antibody, TC113. Cdc25C protein levels were monitored
by direct IB with TC113 without IP. Nonimmune rabbit serum was used as a
control for the IP.
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implicated for UCN-01’s effects on the cell cycle [28]. As
mentioned above, phosphorylation of Chk1 is thought to
activate Chk1 kinase activity, resulting in phosphorylation of
S216 on the phosphatase Cdc25C, which causes its nuclear
export and initiation of G2 arrest [2,7–12].
Although Chk1’s role in this cell cycle checkpoint is well
established, it has not been shown that this checkpoint is
responsive to radiation, and Chk1 kinase activity does not
appear to be activated by ionizing radiation [13,14]. Thus,
the phosphorylation of Cdc25C seems to be uncoupled from
the radiation response. Nevertheless, we sought to deter-
mine whether UCN-01 inhibited phosphorylation of Cdc25C
on S216. To determine the status of S216, we used a
phosphorylation-specific antibody against the S216 of
Cdc25C. Our result shows that phosphorylation of Cdc25C
on S216 was not changed in response to either radiation or
UCN-01 (Figure 3C ). Therefore, it is highly unlikely that
phosphorylation of Cdc25C on S216 by Chk1 regulates
radiation- induced G2 arrest.
Radiation- Induced Phosphorylation of Chk1 on S345 is
p53- Independent and Inhibited by UCN-01
Chk1 is known to be phosphorylated in response to
ionizing radiation at S345 in an ATR-regulated (and possibly
ATM-regulated) manner [5 ]. Despite the lack of effect of
UCN-01 on Chk1’s kinase activity on known substrates, we
wondered whether UCN-01 might inhibit phosphorylation of
Chk1 itself at S345. To test this, phosphorylation of Chk1 on
S345 was assayed by immunoprecipitation, with a phos-
phorylation-specific antibody raised against S345 of Chk1 in
the absence and presence of UCN-01 in both p53+ / + and
p53 /  cells. In response to radiation, Chk1 was phos-
phorylated on S345 regardless of p53 status (Figure 4 ),
which was consistent with a previous report [5 ]. We also
found that UCN-01 inhibited the radiation- induced S345
phosphorylation at drug doses comparable to those that
inhibited cell cycle arrest.
We further probed the immunoprecipitation blots and
found that there was a significant coimmunoprecipitation of
p53 in irradiated wild- type cells, and the precipitates
contained 14-3-3 and p21 as well. This coprecipitation
was inhibited by UCN-01, because UCN-01 inhibited Chk1
phosphorylation at S345 (Figure 4 ). Chk1 was also
phosphorylated in p53 /  cells, yet coprecipitation of p21
and 14-3-3 was not seen, even though baseline levels of
these proteins (Figure 2 ) were sufficiently high to detect
associations. These results suggest that S345 phosphory-
lated Chk1 physically associates with p53, and with down-
stream cell cycle arrest proteins, in a p53-dependent
manner. Thus, protein–protein interactions may provide a
link between Chk1 and p53 that is independent of Chk1’s
kinase activity.
To confirm that there was a radiation- induced associ-
ation of Chk1 with p53, a reciprocal immunoprecipitation
was performed in which p53 antibody (FL393), rather than
Chk1, was immunoprecipitated and Chk1, p21, and 14-3-
3 were probed for by Western blot (Figure 5 ). Once
again, Chk1 showed a radiation- induced coprecipitation
with p53, as well as 14-3-3 and p21, supporting the
previous observation that Chk1 and p53 physically asso-
ciate with p53 following irradiation. In contrast, Ku70 — an
abundant DNA repair protein for radiation- induced DNA
strand breaks that has been reported to be upregulated in
a p53/ATM-dependent fashion [37] — did not coprecipi-
tate with p53.
The recent availability of a 14-3-3 knockout HCT116 cell
line allowed us to test the importance of 14-3-3 to Chk1
binding to p53. When wild- type HCT116 cells were com-
pared to the isogenic 14-3-3 knockout line, the radiation-
induced Chk1 binding to p53 appeared to be 14-3-3
dependent, whereas the p21 binding was not (Figure 5 ).
Thus, p53 and 14-3-3 binding to Chk1 might be interde-
pendent on one another, whereas p21 binding to Chk1 is only
dependent on p53.
p53 is Required for UCN-01–Mediated Radiosensitization
UCN-01 has been reported to preferentially radiosensi-
tize a HPV-E6–expressing tumor cell line relative to the p53
wild- type parent cells [38], and this finding was attributed to
UCN-01’s abrogation of the G2 checkpoint. However, cells
lacking p53 have since been shown to fail to sustain G2
arrest and yet were not radiosensitive [30]. Nevertheless,
14-3-3 and p21 double-mutant cells, expressing wild- type
p53, have been reported to be highly radiosensitive [16],
suggesting that p53 may be required for both cell cycle arrest
and radiosensitivity. Because UCN-01’s suppression of 14-
3-3 and p21, but not p53, mimics the double-mutant
Figure 4. DNA damage–mediated phosphorylation of Chk1 at S345 is
associated with p53 -dependent checkpoint proteins. Phosphorylation of Chk1
on S345 in response to DNA damage and UCN-01 was measured by IP with
antibody against S345p -Chk1 followed by an IB with Chk1 antibody (G4 ).
The complexes of phosphorylated form of Chk1 with p53, 14 -3 - 3, p21, and
IgG were assayed by immunoblotting the membrane with anti –p53 mono-
clonal antibody (DO-1 ), anti –14 -3 -3 goat polyclonal antibody (N -14 ),
anti –p21 monoclonal antibody (WAF1 ), and anti –mouse IgG. The non-
immune serum was used as a control for the IP. Nonimmune serum did not
precipitate Chk1, p53, 14 -3 -3 or p21. (The amounts of extracts used for IPs
were adjusted to have equal Chk1 levels in all lanes. This was confirmed by
direct immunoblotting of whole - cell extracts with G4 anti –Chk1 and anti –
mouse IgG antibodies, as shown in the lower bracketed section. )
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situation in terms of gene expression, we tested UCN-01’s
ability to radiosensitize p53 wild- type and mutated HCT116
cells.
Cells were treated with 100 nM of UCN-01 for 24 hours,
irradiated with increasing doses of radiation, and assayed for
clonogenic survival. Our results demonstrated that UCN-01
specifically radiosensitized the p53+ / + cells (Figure 6 ).
These findings are consistent with the notion that p21 and
14-3-3 cooperate in G2 arrest and that loss of expression
of both proteins, in the presence of wild - type p53, results in
clonogenic radiosensitization [16]. Also, the observation that
UCN-01-mediated radiosensitization is p53-dependent is
consistent with our findings that p21 and 14-3-3 suppres-
sion is p53-dependent.
Chk2 Pathway is not Inhibited by UCN-01
Chk2 is a functional homolog of Chk1 that has also
been shown to phosphorylate p53 at S20 [25,39], and is
thought to be a major activator of p53 [25,39–42]. Like
Chk1, Chk2 is known to be phosphorylated on irradiation
treatment, and cells lacking Chk2 failed to sustain G2
arrest [42]. We wanted to determine whether UCN-01
inhibited radiation- induced phosphorylation of Chk2 as
well as Chk1. Chk2 phosphorylation in response to
radiation and UCN-01 was measured by electrophoretic
band shift (Figure 7 ). Results showed that radiation-
induced phosphorylation of Chk2 was not inhibited by
UCN-01. In fact, UCN-01 alone appeared to induce
phosphorylation, although it is not clear whether UCN-01
directly stimulated phosphorylation of Chk2, or that
phosphorylation was a consequence of a persistent DNA
damage signal due to unresolved DNA strand breakage in
cells with disrupted checkpoints. These findings are
consistent with our earlier observation that UCN-01
enhanced p53 phosphorylation at S20, and suggest that
the Chk2/p53 pathway remains functional in the presence
Figure 7. Phosphorylation of Chk2 in response to DNA damage and UCN-01.
Cells were treated with UCN-01 and / or radiation. Phosphorylation of Chk2
was shown as a shift relative to the untreated sample analyzed by Western
blot with an anti –Chk2 antibody.
Figure 6. p53 is required for UCN -01 mediated radiosensitization.
Colony -formation assay was performed on HCT116 p53+ / + ( top panel )
and p53 / ( bottom panel ) as described in the Materials and Methods
section. After treatment with 0 nM of UCN-01 ( closed square ) or 100 nM
of UCN-01 (open triangle ) for 24 hours, cells were irradiated at varying
dose and replated 24 hours postirradiation in drug - free medium. Colonies
were stained and counted 12 days later. There were three replicate plates
at each dose point within an experiment, and the experiments were done
in triplicate. Error bars represent ±one standard error of the mean.
Figure 5. Chk1, 14 - 3 - 3, and p21 coprecipitates with p53 in wild - type cells
following irradiation. Wild - type and 14 -3 - 3 knockout HCT 116 cells were
irradiated to 10 Gy and extracts were immunoprecipitated with p53 antibody,
FL393 ( rabbit ), followed with immunoblotting with mouse antibodies for Chk1
(G4 ), 14 - 3 - 3 (N -14 ), p21 (WAF1 ), and Ku70 (N3H10 ). [Because p53
and Chk1 are of similar size and cannot be probed on the same blot,
equivalent p53 precipitation was confirmed by Western analysis on a separate
blot using p53 antibody, DO1 (mouse ). The cross - reacting rabbit IgG band
( from FL393 ) on this blot serves as an internal loading control. Analysis of
whole - cell extracts showed Ku70 to be highly expressed in HCT116 cells. ]
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of UCN-01, yet is unable to induce cell cycle arrest. This
further supports the notion that Chk1, and not Chk2, is
affected by UCN-01.
Discussion
Interactions between Chk1 and p53 Cell Cycle Arrest
Pathways
A substantial body of evidence implicates Chk1 as a
central player in the G2 checkpoint in human cells, yet the
nature of its involvement in radiation- induced G2 arrest is
unclear. Nevertheless, Chk1 has been shown to be
phosphorylated in a radiation dose–dependent manner at
S345 [5,43] — a consensus sequence for radiation signal
transduction kinases ATM and ATR — and ATR has been
shown to regulate phosphorylation at S345 in both an
ionizing and UV radiation–dependent manner [5 ]. This
strongly implicates S345 of Chk1 as a mediator of radiation-
induced G2 arrest function, yet it has not been shown that
this phosphorylation alters the kinase activity of Chk1, at
least on its best known substrate, Cdc25C. This raises the
question as to what the functional consequences of Chk1
phosphorylation might be.
Unlike Chk1, however, the transcriptional activity of p53 is
well known to be stimulated by DNA damage. DNA damage
increases the half - life of p53, and increases the expression
of its downstream cell cycle effector proteins, including p21
and 14-3-3 [20,44]. p21 is a well -characterized inhibitor of
cyclin-dependent kinases. It is not only a potent inducer of
G1 arrest [18,44-46], but also plays an important role in G2
arrest [15]. 14-3-3 has been shown to cooperate with p21
in sustaining G2 arrest [16]. Thus, p53’s promotion of G2
arrest is thought to be mediated primarily through the
cooperative effects of these two downstream cell cycle
effector proteins [16,19,20]. HCT116 cells deficient in
expression of both p21 and 14-3-3, yet proficient in p53,
have shortened G2 arrest [16]. It should be noted, however,
that there are some reports that exogenous expression of
wild- type p53 in p53-mutated tumors can actually promote
the release of cells from radiation- induced G2 arrest
[47,48], suggesting that p53 induction may exert negative
as well as positive regulation on G2 arrest. At this time, the
molecular mechanisms underlying p53’s putative negative
regulation of G2 are not known.
An important question is whether the Chk1 pathway for
G2 arrest interacts with the p53-mediated G2 arrest path-
way, and what the mechanism of that interaction might be.
Direct interaction with p53 is a possible means by which
Chk1 might communicate with DNA damage response
pathways and, thus, link Chk1’s cell cycle effects to DNA
damage–induced signal transduction. In fact, S20 of p53 is
known to be one of the substrates for Chk1 kinase activity
[39]; however, it is not clear whether Chk1 regulates p53-
dependent cell cycle checkpoints through phosphorylating
p53 at S20 in vivo. We show here that p53 at S20 remains
normally phosphorylated even when G2 arrest has been
completely inhibited by UCN-01.
It had been reported that Chk1 in fission-yeast was
phosphorylated after DNA damage, and the phosphorylated
form of Chk1 bound to yeast 14-3-3 proteins [43]. This
suggested that a mechanism other than mere activation of
Chk1 kinase activity might be involved in a DNA damage–
induced G2 arrest function, and that the mechanism may
involve protein–protein interactions. This is reminiscent of
other checkpoint mechanisms that rely on protein binding,
such as Cdc25C binding to 14-3-3 proteins. Because both
Chk1 and p53 are required for normal DNA damage
checkpoints, we wondered whether radiation- induced phos-
phorylation of Chk1 S345 might result in physical association
between Chk1 and p53. Our findings support this notion, and
suggest an association between p53, 14-3-3, and p21. In
agreement with the study of Liu and coworkers [5 ], we
showed that Chk1 was phosphorylated on S345 in response
to radiation regardless of p53 status. However, the copre-
cipitation of p21 and 14-3-3 with the phosphorylated Chk1
was found only in p53+ / + cells, even though the p53 / 
cells expressed ample amounts of 14-3-3 and p21,
suggesting that p53 was centrally important to the associ-
ation of these proteins. In reciprocal experiments, where p53
was precipitated, Chk1 coprecipitation appeared to be 14-3-
3 dependent, suggesting that both p53 and 14-3-3 are
required for binding. Interestingly, p21 binding was not
dependent on 14-3-3. Thus, p53 and 14-3-3 binding to
Chk1 might be interdependent on one another, whereas p21
binding to Chk1 is only dependent on p53.
At this point it is not clear how important phosphorylation
of Chk1 is to the radiation- induced G2 arrest pathway. Our
results showing that phosphorylated Chk1 physically asso-
ciates with p53 may provide a new mechanism for the Chk1
G2 arrest pathway to interact with the p53-mediated G2
arrest pathway, and may reveal another level of control of
radiation- induced arrest functions. The issue of Chk1’s
radiation- inducible protein associations and the role of these
associations in radiation- induced G2 arrest need to be
further investigated.
Mechanistic Clues from UCN-01
Studies of the role of Chk1 in radiation- induced G2 arrest
have been hampered because Chk1-deficient cells are not
viable. Therefore, we were intrigued by reports that the
staurosporine analog, UCN-01 — a potent inhibitor of G2
arrest and a protein kinase inhibitor — acted by targeting
Chk1 [27-29]. Furthermore, it was claimed that UCN-01
specifically radiosensitized p53-deficient cells [38], sug-
gesting a possible interactive role for Chk1 and p53 in
radiation- induced G2 arrest.
Although Chk1 has been reported to be the relevant target
for UCN-01, it is also known that the kinase inhibition by
UCN-01 is more broad than simply Chk1 ( including protein
kinase C [49] ) and that radiosensitization potential is
variable among cell types. Nevertheless, UCN-01 remains
a potent inhibitor of G2 arrest ( IC5050 nM) with radio-
sensitization activity that is modified by p53 status. These
results, coupled with our observation that UCN-01 was also
a potent inhibitor of radiation- induced increases in p21 and
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14-3-3, stimulated us to further investigate the of effects of
this drug on cell cycle regulatory proteins, as a tool to find
clues to critical protein targets for cell cycle arrest inhibition.
Despite the fact that UCN-01 is a kinase inhibitor with
questionable target specificity, of the known phosphorylation
sites on major proteins controlling G2 cell cycle arrest only
S345 of Chk1 is known to be both radiation inducible and
UCN-01 inhibitable. Thus, regardless of the kinase activity,
which is targeted by UCN-01, its inhibition of S345 may be
an important mediator of its radiation- induced cell cycle
effects. These findings suggest that phosphorylation of Chk1
at S345 and the suppression of p21/14-3-3may be linked,
and that this linkage may be mediated by binding of S345
phosphorylated Chk1 to p53, 14-3-3, and possibly other
proteins. These are provocative findings need to be further
explored in genetically based cell models.
Cell Cycle Proteins as Radiotherapeutic Targets
Because cell cycle arrest is a downstream event of signal
transduction processes, in which some of the upstream
effector proteins are known, it is intuitively logical that
targeting the known upstream transducing proteins would
inhibit cell cycle arrest functions and promote cell killing.
However, many of these transducing proteins produce
multiple signals, some of which even promote programmed
cell death. It is increasingly becoming evident that cell cycle
regulation and cell death processes are orchestrated in
pathways with common protein players. Furthermore, many
of these processes are modulated by downstream feedback
proteins, which further complicate mechanisms. Thus, the
fate of a DNA-damaged cell may very well depend on how
faithfully the different players fulfill their functional roles and
the overall balance of those events.
In terms of p53, it is possible to view the radioresponse of
p53 as a competition between cell cycle arrest and cell death
[50,51]. The normal elevation of p53 levels following
irradiation, even while downstream cell cycle arrest proteins
are inhibited, such as we saw for UCN-01, may allow p53 to
remain active in cell killing even though its arrest functions
are inhibited. This could explain why we only saw UCN-01
radiosensitization in p53 wild- type cells. This situation could
have some general implications for cell cycle targeting
strategies. Because cell cycle proteins may be players in
both arrest and death function, there may be therapeutic
benefits to be gained by specifically targeting downstream
functions that have segregated to cell cycle arrest, rather
than proteins upstream of both arrest and death functions. In
this way, cell cycle arrest and cell killing might be uncoupled
and manipulated for therapeutic advantage. This notion is
supported by a report of a 14-3-3 and p21 double-
knockout cell line showing a loss of radiation- induced cell
cycle arrest accompanied by increased clonogenic radio-
sensitivity, whereas p53 single knockouts had radiation
survival comparable to wild - type cells [16]. In any event,
downstream cell cycle arrest proteins may prove to be very
important targets for enhancing radiotherapy and other DNA
damage–based cancer treatments. This area needs further
investigation.
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